MeSH tree: C12.200
A drug previously developed at UCLA to help heart tissue repair itself after a heart attack might also help kidney tissue repair and regenerate, researchers have found.
Jun 16, 2026
0
1642
Many medicines begin life with one purpose and end up proving useful for a completely different reason.
Jun 16, 2026
0
4
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...
Jun 16, 2026
0
4
Mayo Clinic researchers have identified a previously unrecognized way the kidneys regulate water balance—an advance that could lead to improved treatments for polycystic kidney disease (PKD) and other disorders. The study, ...
Jun 16, 2026
0
199
Female patients with kidney failure are significantly less likely to be referred to a transplant center for assessment, according to a new study from ICES, London Health Sciences Center Research Institute (LHSCRI) and Western ...
Jun 15, 2026
0
3
Early results from a UCL- and UCLH-led clinical trial suggest that a type of CAR T-cell therapy—developed by Autolus Therapeutics, a UCL spinout—could offer a new treatment approach for people with severe, treatment-resistant ...
Jun 15, 2026
0
7
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
5
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component ...
Jun 15, 2026
0
3
Kidney transplantation remains the most effective treatment for end-stage kidney disease, yet a severe shortage of donor organs continues to limit access for millions of patients worldwide. With demand for kidney transplants ...
Jun 11, 2026
0
4
An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for innovative imaging research that may help physicians identify patients at increased risk of chronic kidney disease ...
Jun 9, 2026
0
4
